Skip to main content
OpenTrials

Clinical trial condition

Sexually Transmitted Diseases, Viral

Explore clinical trials studying Sexually Transmitted Diseases, Viral. Study availability and eligibility vary by location and protocol.

6,131 public trials 362 recruiting studies
Refine in advanced search Browse all conditions

Sexually Transmitted Diseases, Viral trial results

Completed

An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)

NCT02831764

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site San Francisco, California, United States
View all 105 locations
View Trial Details
Completed

A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions

NCT00144248

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +14 more
Locations
  • Boehringer Ingelheim Investigational Site Bakersfield, California, United States
  • Boehringer Ingelheim Investigational Site San Francisco, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • Albany Medical College, MC 142 Albany, New York, United States
View Trial Details
Completed

3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study

NCT00275444

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • Boehringer Ingelheim Investigational Site Fountain Valley, California, United States
  • Living Hope Clinical Trials, Inc. Long Beach, California, United States
  • Boehringer Ingelheim Investigational Site Los Angeles, California, United States
View all 62 locations
View Trial Details
Completed

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients

NCT00056641

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • Boehringer Ingelheim Investigational Site Berkeley, California, United States
  • Boehringer Ingelheim Investigational Site Fountain Valley, California, United States
  • Boehringer Ingelheim Investigational Site Los Angeles, California, United States
View all 109 locations
View Trial Details
Completed

Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)

NCT05152953

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Auburn University Harrison School of Pharmacy Auburn, Alabama, United States
  • University of California San Francisco School of Pharmacy San Francisco, California, United States
  • Nova Southeastern University College of Pharmacy Fort Lauderdale, Florida, United States
  • Texas A&M Irma Lerma Rangel College of Pharmacy Kingsville, Texas, United States
View Trial Details

Related conditions